Transparency and Ethical Business Practice

We know that our patients, and all stakeholders seek assurance that Teva acts lawfully, ethically and responsibly, and increasingly, stakeholders are transparent about our business practices and not only our medicines.
Transparency and Ethical Business Practice
We aim to maintain the trust of our stakeholders in our company and our people by upholding high standards of responsible and ethical behavior. This includes maintaining a culture of ethics and compliance and ensuring our approach is embedded throughout our supply chain. Each year, we aim to increase the transparency of our practices to ensure all our stakeholders can make informed decisions.

Governance, ethics and transparency highlights in 2015

  • Engaged 100% of our newly hired employees worldwide to complete a training course in our Code of Conduct achieving a 93% completion rate.
  • Engaged 100% of our eligible newly hired employees worldwide to complete our Anti-Corruption training course, achieving a 97% completion rate.
  • Complied with Medicines for Europe’s industry Code of Conduct on Interactions with the Healthcare Community published in February 2015.
  • Completed 46 country audits and tested almost 5,500 transactions in more than 35 countries via our Global Internal Audit department in 2014 and 2015.
  • Raised awareness of our Teva Integrity Hotline with 1,400 posters to 46 countries in 38 languages.
  • Reported with disclosures from the Global Reporting Initiative (GRI) G4 sustainability reporting standards.
  • Complied with our commitment to submit an annual Communication on Progress to the UN Global Compact.